Your browser doesn't support javascript.
loading
Inhibition of drug-metabolizing enzymes by Jingyin granules: implications of herb-drug interactions in antiviral therapy.
Zhang, Feng; Liu, Wei; Huang, Jian; Chen, Qi-Long; Wang, Dan-Dan; Zou, Li-Wei; Zhao, Yong-Fang; Zhang, Wei-Dong; Xu, Jian-Guang; Chen, Hong-Zhuan; Ge, Guang-Bo.
Afiliación
  • Zhang F; Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • Liu W; Institute of Liver Diseases, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • Huang J; Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • Chen QL; Pharmacology and Toxicology Division, Shanghai Institute of Food and Drug Control, Shanghai, 201203, China.
  • Wang DD; Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • Zou LW; SPH Xing Ling Sci. & Tech. Pharmaceutical Co., Ltd, Shanghai, 201703, China.
  • Zhao YF; Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • Zhang WD; Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • Xu JG; Institute of Liver Diseases, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • Chen HZ; Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • Ge GB; Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Acta Pharmacol Sin ; 43(4): 1072-1081, 2022 Apr.
Article en En | MEDLINE | ID: mdl-34183756

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Subtipo H1N1 del Virus de la Influenza A / Tratamiento Farmacológico de COVID-19 Idioma: En Revista: Acta Pharmacol Sin Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Subtipo H1N1 del Virus de la Influenza A / Tratamiento Farmacológico de COVID-19 Idioma: En Revista: Acta Pharmacol Sin Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article